A way forward for research on biomarkers for psychiatric disorders.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Metabolomics in Depression: What We Learn from Preclinical and Clinical Evidences.Molecular neurobiology · 2025
   Pooled it
2. Candidate Biological Markers for Social Anxiety Disorder: A Systematic Review.International journal of molecular sciences · 2023
   Pooled it
3. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.The international journal of neuropsychopharmacology · 2015
   Trial
4. Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2023
   Article
5. Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers.Translational psychiatry · 2022
   Article
6. Biomarkers in Psychiatric Disorders.Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees · 2022
   Article
7. Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.International journal of molecular sciences · 2022
   Review
8. Ethical Development of Digital Phenotyping Tools for Mental Health Applications: Delphi Study.JMIR mHealth and uHealth · 2021
   Article
9. Biological Markers in Anxiety Disorders.Journal of clinical medicine · 2021
   Review
10. Targeted Metabolic Profiling of Urine Highlights a Potential Biomarker Panel for the Diagnosis of Alzheimer's Disease and Mild Cognitive Impairment: A Pilot Study.Metabolites · 2020
    Article
11. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study.European archives of psychiatry and clinical neuroscience · 2020
    Article
12. Urinary Amine and Organic Acid Metabolites Evaluated as Markers for Childhood Aggression: The ACTION Biomarker Study.Frontiers in psychiatry · 2020
    Article
13. Plasma Metabolite Profiles in First Episode Psychosis: Exploring Symptoms Heterogeneity/Severity in Schizophrenia and Bipolar Disorder Cohorts.Frontiers in psychiatry · 2020
    Article
14. Risk Factors Associated with Mild Cognitive Impairment among Apparently Healthy People and the Role of MicroRNAs.Open access Macedonian journal of medical sciences · 2019
    Article
15. Exploring attentive task-based connectivity for screening attention deficit/hyperactivity disorder children: a functional near-infrared spectroscopy study.Neurophotonics · 2019
    Article
16. The Effects of Three Kinds of Insurance Benefit Design Features on Specialty Mental Health Care Use in Managed Care.The journal of mental health policy and economics · 2019
    Article
17. Biological and Clinical Markers in Panic Disorder.Psychiatry investigation · 2019
    Article
18. Advances in microstructural diffusion neuroimaging for psychiatric disorders.NeuroImage · 2018
    Review
19. Knowledge discovery for Deep Phenotyping serious mental illness from Electronic Mental Health records.F1000Research · 2018
    Article
20. Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.Journal of neuroinflammation · 2017
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as